Abstract Photodynamic therapy (PDT) is a useful strategy for treating various cancers. Details of the mechanisms of PDT have not been made clear yet. We intended to study the efficacy of PDT in relation to the cell cycle. HeLa S3 cells were synchronized by the thymidine block method. Cells in different cell cycle phases after release were treated with the water-soluble photosensitizer, ATX-S10(Na). The cellular viability after PDT was determined by the MTT assay. Intracellular levels of ATX-S10(Na) in different cell cycle phases were also determined. We found that cells in the S and G 2 /M phases were hypersensitive to PDT with ATX-S10(Na) in comparison with those in the G 1 phase, and that cellular levels of ATX-S10(Na) were increased in cells in the S and G 2 /M phases compared to those in the G 1 phase. We conclude that cellular ATX-S10(Na) levels differ among the different cell cycle phases, which is associated with the cell-cycle-dependent efficacy of PDT with ATX-S10(Na).
Introduction
Photodynamic therapy (PDT) is an effective strategy for the treatment of various malignancies [1, 2] . PDT can induce lethal damage in cancer cells selectively because of its selective incorporation of photosensitizers to cancer cells rather than normal cells. However, there is often a substantial recurrence of malignancies [3, 4] . Therefore, to clarify the detailed mechanisms of PDT, it is important to improve the efficiency of the technique.
Several studies have demonstrated that the effects of PDT depend on cell cycle phases. In the case of the PDT with hematoporphyrin derivatives, cells in the middle S phase are the most sensitive [5, 6] . In the case of the PDT with aminolevulinic acid, cells in the S and G 2 phases are particularly sensitive due to increased production of protoporphyrin IX [7] . Therefore, the effects of PDT with chemotherapeutic agents vary in the different cell cycle phases, which should be taken into the consideration for the development of optimized PDT. The studies of Ma et al. [8] [9] [10] [11] showed that the sensitivity of cells to PDT can be increased by mitomycin C because mitomycin C induces S-phase-block in cells, resulting in an increase in the fraction of cells in the S phase prior to PDT.
Recently, a number of hydrophilic photosensitizing agents have been intensively studied. However, the relationship between the cell cycle phase and cellular sensitivity to PDT with these agents is still poorly understood.
In the present study, we aimed to investigate the relationship between cell cycle phases and photosensitivity to a water-soluble photosensitizer, ATX-S10(Na), in synchronized HeLa cells that originated from cervix cancer, which is of good indication for PDT.
2,7,12,18-tetramethylporphyrin sodium salt was provided by Photochemical Co. Ltd (Okayama, Japan). This compound was dissolved in phosphate-buffered saline (PBS) at a concentration of 2 mg/ml, aliquoted, and stored at À20°C. Further dilutions were made in culture medium immediately prior to experiments.
Cell cultures
HeLa S3 cells were obtained from Riken Cell Bank (Tsukuba, Japan). The cells were maintained in Eagle's minimum essential medium supplemented with 10% calf serum (CS), 2 mM glutamine, 100 U/ml penicillin, and 100 mg/ml strepromycin (all from Gibco BRL, Gland island, NY, USA) at 37°C in a humidified 5% CO 2 atmosphere.
Cell synchronization
Synchronization of HeLa S3 cells was accomplished by a single thymidine block method, as reported by Stein [12] , with minor modification. Briefly, exponentially growing cells were treated with complete media containing 2 mM thymidine (Sigma Chemical, St. Louis, MO, USA) for 16 h. Then, the cells were released from the thymidine block by washing twice with PBS at 37°C and replacement with fresh media containing 24 lM deoxycytidine (Sigma Chemical). After release, the cells were sampled at 2-h or 3-h intervals, and then subjected to the flow cytometry analysis to check synchronization and cellcycle progression, as described below.
Flow cytometry analyses
Flow cytometry was used to determine the proportion of cells in each phase of the cell cycle at different times after release from the thymidine block. HeLa S3 cells were trypsinized and centrifuged at 450· g for 5 min. While vortexing, 70% ethanol was added and the cells were incubated at 4°C overnight. Following a brief exposure to 0.25 lg/ml RNAase (Sigma Chemical), cellular DNA was stained with 50 lg/ml propidium iodide (Sigma Chemical). After filtration through nylon mesh to avoid clumps, the cells were subjected to an Epics XL flow cytometer (Beckman Coulter, Fullerton, CA, USA). The resultant synchronized DNA histograms were analyzed using Multicycle analysis software (Phoenix Flow Systems, San Diego, CA), which determined the percentage of cells in different cell cycle phases at each time point. The experiment was repeated four times.
ATX-S10(Na)-PDT treatment HeLa S3 cells were seeded in 96-well plates (Falcon Multiwell 96-well, Becton Dickinson, Franklin Lakes, NJ, USA) at cell density of 6·10 3 /cm 2 . Forty-eight hours after seeding, the cells were synchronized by the thymidine block procedure, as described above. At times corresponding to S, G 2 /M, and G 1 phases of the cell cycle, the medium was replaced with 100 ll per well medium with 5 lg/ml, 10 lg/ml, and 25 lg/ml ATX-S10(Na) and 1% CS. After 2 h in the incubator, the ATX-S10(Na) solution was removed, the cells were carefully washed twice with medium, and 100 ll of drugfree medium was added to each well. The cells were then irradiated with a diode laser (Hamamatsu Photonics KK, Hamamatsu, Japan) using a wavelength of 670 nm with a dose of 20 J/cm 2 . The power density was adjusted to 160 mW/cm 2 . Controls for ATX-S10(Na) alone and irradiation alone were also performed.
Assessment of phototoxicity using MTT assay
Following irradiation, the cells in the 96-well microplates were incubated for 24 h. Then, measurement of mitochondrial dehydrogenase activity was carried out by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay [13, 14] . MTT solution was added to each well at a concentration of 0.5 mg/ml, and the plates were incubated at 37°C for 4 h. Acid-isopropanol (0.04 N HCl in isopropanol) was added and mixed to solubilize the formazan. The plate was then read on an EL340 microplate reader (Bio-Tek, Winooski, VT, USA) using a wavelength of 562 nm.
Measurement of ATX-S10(Na) levels in cells
The cells were seeded in 10 cm 2 tissue culture wells (Falcon Mutiwell 6-well, Becton Dickinson) at a cell density of 6·10 3 /cm 2 . The cells were cultivated for 48 h and synchronized as above. At times corresponding to each phase of the cell cycle after release of the thymidine block, the cells were incubated with 10 lg/ml ATX-S10(Na) in medium supplemented with 1% CS for 2 h in the dark at 37°C. Afterwards, the cells were washed three times with PBS, and ATX-S10(Na) was extracted from the cells by 1% aqueous sodium dodecylsulfate (Wako Pure Chemical, Osaka, Japan). The content of ATX-S10(Na) in the supernatants was quantitatively determined by recording emission spectra of the samples using a F-4010 fluorescence spectrophotometer (Hitachi High-Technologies, Tokyo, Japan). The excitation wavelength was 413 nm, the slit width corresponded to a resolution of 20 nm and the emission wavelength was scanned from 600 nm to 700 nm. The fluorescence intensity of the samples at the 670-nm emission peak was compared with the standard line ( Fig. 1) made by emission peak levels of the different concentrations (0, 5, 25, 50, 125, 250 ng/ml) of ATX-S10(Na). The cell count was determined using a Burker-Turk hemocytometer. Five triplicate experiments for each cell density were performed.
Statistical analyses
All data are presented as means±the standard deviation of the mean (SD). Statistical analyses were carried out using one-way analysis of variance (one-way ANOVA), followed by the Scheffe's multiple comparison test. Statistical significance was accepted if P<0.05.
Results
We first examined the cell-cycle progression of HeLa cells after release from the synchronization to the G 1 (Fig. 2) . The percentage of cells in the S phase was highest at 2 h after release, that in the G 2 /M phase was highest at 6 h after release, and that in the G 1 phase was highest at 10-12 h after release. On the basis of these results, the 2-h ATX-S10(Na) treatment of cells in different cell cycle phases was performed from 1.5 h to 3.5 h (S-phase cells), from 5.5 h to 7.5 h (G 2 /M-phase cells), and from 10 h to 12 h (G 1 -phase cells) after release. We have already reconfirmed that incubation of cells in media containing ATX-S10(Na) at a concentration of 25 lg/ml for 2 h had no detectable effect on cellcycle progression and cell viability (data not shown).
We incubated HeLa S3 cells in the different cell cycle phases with different concentrations of ATX-S10(Na). Cells synchronized at the different cell cycle phases according to the above mentioned time points were treated with ATX-S10 at the indicated concentrations for 2 h. Immediately after 2-h incubation, the cells were exposed to the laser irradiation. Cell viability at 24 h after irradiation measured by an MTT assay decreased in a dose-dependent manner of ATX-S10(Na). We also found that cells in the S or G 2 /M phases were more hypersensitive to the treatment in comparison with cells treated during the G 1 phase (Fig. 3) . When the cells were treated with 10 lg/ml of ATX-S10(Na) for 2 h, their survival in the S and G 2 /M phases after exposure to the laser were significantly lower than that in the G 1 phase, respectively 37.0%, 38.9%, and 56.7%.
We investigated whether there were differences in cellular ATX-S10(Na) levels among cells in the different Fig. 1 Relationship between the peak emission levels and the known concentrations of ATX-S10(Na). The peak emission levels were significantly correlated with the concentrations of ATX-S10(Na) (r=0.991, P=0.0001). The regression line was expressed as follows: y=0.058x+2.777; y is the fluorescent intensity [arbitrary unit (au)], x is the concentration of ATX-S10(Na) Fig. 2 Time-dependent differences in the cell-cycle distributions of HeLa S3 cells after release from cell-cycle synchronization with treatment using 2 mM thymidine for 16 h. Data represent the mean+SD of five separate experiments Fig. 3 The viability of HeLa S3 cells in different cell cycle phases after PDT with diode laser (20 J/cm 2 ) and indicated concentrations of ATX-S10(Na). The viability of cells treated during the S and G 2 / M phases were significantly lower than that during the G 1 phase when concentrations of ATX-S10(Na) were 5 lg/ml, 10 lg/ml, and 25 lg/ml. The data represent the mean±SD of five separate experiments. *P<0.05 compared with control. **P<0.01 compared with control at each concentration cell cycle phases. After incubation of cells in different cell cycle phases with ATX-S10(Na) at a concentration of 10 lg/ml for 2 h, the intracellular concentration ATX-S10(Na) per 10 5 cells in the S and G 2 /M phases was significantly higher than that in the G 1 phase (43.9, 36.2, and 25, respectively, Fig. 4) .
Discussion
The present study demonstrated that HeLa S3 cells in the S and G 2 /M phases were more hypersensitive to PDT with ATX-S10(Na). We also found that the intracellular levels of ATX-S10(Na) in HeLa S3 cells in the S and G 2 /M phases were increased in comparison with those in the G1 phase, which might be associated with an increase in sensitivity of HeLa S3 cells to PDT in the S and G 2 /M phases.
Our flow cytometry findings are in agreement with the report of Shibata et al., where the ATX-S10(Na) uptake of synchronous glioma cells in the G 2 /M phase was higher than that of cells in the G 0 /G 1 phase. They proposed that the ATX-S10(Na) uptake depends on the amounts of low-density lipoprotein (LDL) receptors, which differ among different cell cycle phases [15] . Nakajima et al. [16] reported that tumor-specific glycoprotein, whose domain structure was the same as that of hemopexin, was an important carrier protein, which contributed to the tumor-cell-specific incorporation of water-soluble photosensitizer, such as ATN-2 and ATX-S10(Na).
It is conceivable that cell surface area is a major determinant of the cellular levels of ATX-S10(Na). The early study by Steen et al. [17] showed that the size of synchronized NHIK 3025 cells, originating from a cervical carcinoma, increased linearly with time through the cell cycle. Furthermore, Ma et al. [8] reported that the surface area of unsynchronized WiDr cells, a human colon adenocarcinoma, increased as they passed through the cell cycle from the G 0 /G 1 to G 2 /M phase and that Photofrin II fluorescence was roughly proportional to the cell surface area. Therefore, the difference in cell sizes in different cell cycle phases could, to some extent, affect the cell-cycle-dependent incorporation of ATX-S10(Na).
The differential sensitivity to reactive oxygen species induced by PDT at different phases of the cell cycle could be another mechanism for cell-cycle-dependent cellular sensitivity to PDT. Berg et al. [18] [19] [20] demonstrated that PDT with several photosensitizers, including Photofrin II, tetra (3-hydroxyphenyl) porphyrin (3-THPP), sulphonated tetraphenyl porphines (TPPS 1-4 ), and tetrasulphonated aluminum phthalocyanine (AlPcS 4 ), resulted in the accumulation of cells in mitotic phase, and subsequently followed by cell death. Furthermore, they reported that PDT-induced mitotic arrest was caused by the damage of microtubules and that the accumulation in mitosis was more extensive after treatment with hydrophobic sensitizers than after treatment with hydrophilic ones, since the tubulin/microtubule system is mainly located in the cytosol, therefore, hydrophilic sensitizers could easily damage tubulin and/ or microtubule [19] . ATX-S10(Na) was distributed not only to lysosomes, but also to cytosol [21] . Therefore, the tubulin/microtubule-related mechanism could be involved in the cell-cycle-dependent sensitivity to PDT with ATX-S10(Na).
It is known that PDT in combination with chemotherapy is promising. With the combination therapy, not only is the therapeutic efficacy of cancer treatment increased, but also, the dose of photosensitizers and chemotherapeutic drugs can be decreased, thereby, leading to a reduction in adverse events due to photosensitizers and chemotherapeutic drugs, such as skin burn. To date, it has been demonstrated that mitomycin C makes the cancer cells more sensitive to Photofrin-PDT in vitro and in vivo by induction of S-phase arrest in cancer cells [9] [10] [11] 22] . Furthermore, the effect of PDT on tumor cells can be enhanced by the microtubule inhibitors, such as vincristine, taxol, and nocodazol, which arrest cells in mitosis [23, 24] . Because of the high sensitivity of cells in the S and G 2 /M phases to PDT with ATX-S10(Na), as demonstrated in the present study, we anticipate the possibility for the synergistic effect of ATX-S10(Na) PDT and chemotherapy that induces Sor G 2 /M-phase arrest.
In conclusion, we demonstrated that the efficacy of PDT with ATX-S10(Na) depended on the cell cycle. PDT is now clinically used for various types of cancer. Our study reconfirmed the relevance of consideration of the cell cycle in the cancer treatment and suggests the mechanism of possible usefulness of the combination of PDT with some appropriate chemotherapeutic agents, which induce cell cycle arrest at the S or G2/M phases. We hope that our study could be the basis for Fig. 4 Cellular ATX-S10(Na) levels at different cell cycle phases. HeLa S3 cells in G1, S, and G2/M phases were incubated with 10 lg/ml ATX-S10(Na) for 2 h. The mean cellular ATX-S10(Na) level was significantly increased in the S-and G 2 /M-phase cells than in G 1 cells. The data represent the mean±SD of five separate experiments. *P<0.05 compared with G1 combination therapy with PDT and chemotherapy. However, whether concomitant treatment with ATX-S10(Na) PDT and chemotherapy is clinically useful and effective should be tested in the future under the appropriate study design.
